Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.

Yokoyama Y, Lew ED, Seelige R, Tindall EA, Walsh C, Fagan PC, Lee JY, Nevarez R, Oh J, Tucker KD, Chen M, Diliberto A, Vaaler H, Smith KM, Albert A, Li G, Bui JD.

Cancer Res. 2019 Apr 15;79(8):1996-2008. doi: 10.1158/0008-5472.CAN-18-2022. Epub 2019 Feb 5.

PMID:
30723115
2.

Clinical presentation of prostate cancer in black South Africans.

Tindall EA, Monare LR, Petersen DC, van Zyl S, Hardie RA, Segone AM, Venter PA, Bornman MS, Hayes VM.

Prostate. 2014 Jun;74(8):880-91. doi: 10.1002/pros.22806. Epub 2014 Apr 9.

3.

Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa.

Tindall EA, Bornman MS, van Zyl S, Segone AM, Monare LR, Venter PA, Hayes VM.

BMC Urol. 2013 Dec 29;13:74. doi: 10.1186/1471-2490-13-74.

4.

Complex patterns of genomic admixture within southern Africa.

Petersen DC, Libiger O, Tindall EA, Hardie RA, Hannick LI, Glashoff RH, Mukerji M; Indian Genome Variation Consortium, Fernandez P, Haacke W, Schork NJ, Hayes VM.

PLoS Genet. 2013;9(3):e1003309. doi: 10.1371/journal.pgen.1003309. Epub 2013 Mar 14.

5.

A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiency.

Saunders DN, Tindall EA, Shearer RF, Roberson J, Decker A, Wilson JA, Hayes VM.

PLoS One. 2012;7(12):e51762. doi: 10.1371/journal.pone.0051762. Epub 2012 Dec 12.

6.

Interleukin-6 promoter variants, prostate cancer risk, and survival.

Tindall EA, Severi G, Hoang HN, Southey MC, English DR, Hopper JL, Giles GG, Hayes VM; Australian Prostate Cancer BioResource.

Prostate. 2012 Dec 1;72(16):1701-7. doi: 10.1002/pros.22557. Epub 2012 Jul 10.

PMID:
22782910
7.

Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil).

Miller W, Hayes VM, Ratan A, Petersen DC, Wittekindt NE, Miller J, Walenz B, Knight J, Qi J, Zhao F, Wang Q, Bedoya-Reina OC, Katiyar N, Tomsho LP, Kasson LM, Hardie RA, Woodbridge P, Tindall EA, Bertelsen MF, Dixon D, Pyecroft S, Helgen KM, Lesk AM, Pringle TH, Patterson N, Zhang Y, Kreiss A, Woods GM, Jones ME, Schuster SC.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12348-53. doi: 10.1073/pnas.1102838108. Epub 2011 Jun 27. Erratum in: Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18625.

8.

The 4q27 locus and prostate cancer risk.

Tindall EA, Hoang HN, Southey MC, English DR, Hopper JL, Giles GG, Severi G, Hayes VM.

BMC Cancer. 2010 Feb 25;10:69. doi: 10.1186/1471-2407-10-69.

9.

Interpretation of custom designed Illumina genotype cluster plots for targeted association studies and next-generation sequence validation.

Tindall EA, Petersen DC, Nikolaysen S, Miller W, Schuster SC, Hayes VM.

BMC Res Notes. 2010 Feb 22;3:39. doi: 10.1186/1756-0500-3-39.

10.

Complete Khoisan and Bantu genomes from southern Africa.

Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, Harris RS, Petersen DC, Zhao F, Qi J, Alkan C, Kidd JM, Sun Y, Drautz DI, Bouffard P, Muzny DM, Reid JG, Nazareth LV, Wang Q, Burhans R, Riemer C, Wittekindt NE, Moorjani P, Tindall EA, Danko CG, Teo WS, Buboltz AM, Zhang Z, Ma Q, Oosthuysen A, Steenkamp AW, Oostuisen H, Venter P, Gajewski J, Zhang Y, Pugh BF, Makova KD, Nekrutenko A, Mardis ER, Patterson N, Pringle TH, Chiaromonte F, Mullikin JC, Eichler EE, Hardison RC, Gibbs RA, Harkins TT, Hayes VM.

Nature. 2010 Feb 18;463(7283):943-7. doi: 10.1038/nature08795.

11.

Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation.

Tindall EA, Hayes VM.

DNA Res. 2010 Apr;17(2):117-22. doi: 10.1093/dnares/dsq003. Epub 2010 Feb 12.

12.

Inflammatory genetic markers of prostate cancer risk.

Tindall EA, Hayes VM, Petersen DC.

Cancers (Basel). 2010 Jun 8;2(2):1198-220. doi: 10.3390/cancers2021198.

13.

Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.

Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE.

Clin Cancer Res. 2009 Sep 1;15(17):5338-49. doi: 10.1158/1078-0432.CCR-08-2865. Epub 2009 Aug 25.

14.

Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments.

Tindall EA, Petersen DC, Woodbridge P, Schipany K, Hayes VM.

Hum Mutat. 2009 Jun;30(6):876-83. doi: 10.1002/humu.20919.

PMID:
19280649
15.

Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.

Cardiel MH, Tumlin JA, Furie RA, Wallace DJ, Joh T, Linnik MD; LJP 394-90-09 Investigator Consortium.

Arthritis Rheum. 2008 Aug;58(8):2470-80. doi: 10.1002/art.23673.

16.

Yesterday, today, and tomorrow.

Tindall EA.

Arthritis Rheum. 2006 Apr;54(4):1029-33. No abstract available.

17.

Treatment for rheumatic disorders.

Tindall EA, Fox DA.

N Engl J Med. 2006 Mar 23;354(12):1322-3. No abstract available.

PMID:
16554540
18.

Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT.

J Rheumatol. 2003 Apr;30(4):691-6.

PMID:
12672185
19.

A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib.

Tindall EA, Sharp JT, Burr A, Katz TK, Wallemark CB, Verburg K, Lefkowith JB.

Clin Ther. 2002 Dec;24(12):2051-63.

PMID:
12581544

Supplemental Content

Loading ...
Support Center